TS levels vary widely in the tumors of patients with CRC [36] and, although the literature regarding TS as a predictive and prognostic biomarker for 5-FU is inconclusive, some studies show a correlation between TS expression and 5-FU activity [36–39]. This evidence concerns the gene TYMS and colorectal carcinoma.